Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Batus, M. [1 ]
Mohajer, R. [1 ]
Pach, D. [1 ]
Basu, S. [1 ]
Fidler, M. J. [1 ]
Bonomi, P. D. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18047
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase Ib/II study of DMXAA combined with carboplatin and paclitaxel in non-small cell lung cancer (NSCLC).
    McKeage, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 389S - 389S
  • [22] Phase II trial of carboplatin, paclitaxel plus vinorelbine in non-small cell lung cancer patients
    Schmittel, A
    Siehl, JM
    Schulze, M
    Schulze, K
    Thiel, E
    Keilholz, U
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1333 - 1336
  • [23] Phase II clinical trial of Gemcitabine and ifosfamide in inoperable non-small cell lung cancer (NSCLC)
    Cubedo, R
    Espana, P
    Provencio, M
    Jorge, M
    Sanchez, A
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [24] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Concurrent paclitaxel and radiation therapy in stage IIIA/B non-small cell lung cancer: Results of a phase II trial
    Wolf, M
    Faoro, C
    Goerg, C
    Pfab, R
    Havemann, K
    Kettner, H
    SEMINARS IN RADIATION ONCOLOGY, 1997, 7 (02) : S6 - S10
  • [26] Phase II study of celecoxib and weekly paclitaxel in the treatment of pretreated advanced non-small cell lung cancer (NSCLC).
    Stani, SC
    Carillio, G
    Meo, S
    Morabito, A
    Bonginelli, P
    Comella, G
    Mansueto, G
    Avallone, A
    Gion, M
    Gasparini, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 700S - 700S
  • [27] Paclitaxel poliglumex vs. docetaxel for the second-line treatment of non-small cell lung cancer (NSCLC): the STELLAR 2 phase III study
    不详
    EJC SUPPLEMENTS, 2005, 3 (04): : 14 - 14
  • [28] Pre- and post-treatment PET/CT to evaluate the response of non-small cell lung cancer (NSCLC) treated with curative radiotherapy alone (RT)
    Faria, S.
    Lisbona, R.
    Stern, J.
    Souhami, L.
    Portelance, L.
    Devic, S.
    Freeman, C.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S50 - S50
  • [29] Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy
    Yoh, Kiyotaka
    Kubota, Kaoru
    Kakinuma, Ryutaro
    Ohmatsu, Hironobu
    Goto, Koichi
    Niho, Seiji
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    LUNG CANCER, 2007, 58 (01) : 73 - 79
  • [30] Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer
    Natale, RB
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 51 - 54
12345